Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
922studies shown
Showing 1-25 of 922
RecruitingNCT05973786

The Effect of a Six Week Intensified Pharmacological Treatment for Depression in bipolarity Compared to Treatment as Usual in Subjects Who Had a First-time Treatment Failure on Their First-line Treatment.

This study is recruiting. It focuses on depression and currently lists participation information in Austria, Germany, Greece, Italy, Spain, and the United Kingdom.

DepressionOtherOver 18 Years
Countries
Austria, Germany, Greece, Italy, Spain, United Kingdom
Sponsor
Dr. Inge Winter
Condition
Depression
RecruitingNCT06412315

7T Amygdala and Citalopram Study

This study is recruiting. It focuses on depression and currently lists participation information in the United Kingdom.

DepressionDrugFrom 18 Years to 40 Years
Countries
United Kingdom
Sponsor
University of Oxford
Condition
Depression
RecruitingNCT07412756

A Study of Brenipatide in Adult Participants With Major Depressive Disorder

This study is recruiting. It focuses on depression and currently lists participation information in Australia, Brazil, Canada, China, Germany, Greece, Japan, Mexico, Poland, the United States, South Korea, Spain, Taiwan, and the United Kingdom.

DepressionOtherFrom 18 Years to 75 Years
Countries
Australia, Brazil, Canada, China, Germany, Greece, Japan, Mexico, Poland, United States, South Korea, Spain, Taiwan, United Kingdom
Sponsor
Eli Lilly and Company
Condition
Depression
RecruitingNCT06793397

A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder

This study is recruiting. It focuses on depression and currently lists participation information in Australia, Czech Republic, Germany, Greece, Ireland, Poland, the United Kingdom, and the United States.

DepressionOtherFrom 18 Years to 85 Years
Countries
Australia, Czech Republic, Germany, Greece, Ireland, Poland, United Kingdom, United States
Sponsor
Cybin IRL Limited
Condition
Depression
RecruitingNCT07300969

A Study to Evaluate the Effectiveness of DT-101 in Patients With Depression

This study is recruiting. It focuses on depression and currently lists participation information in Bulgaria, Czech Republic, Poland, the United Kingdom, and the United States.

DepressionOtherFrom 18 Years to 75 Years
Countries
Bulgaria, Czech Republic, Poland, United Kingdom, United States
Sponsor
Draig Therapeutics Ltd
Condition
Depression
RecruitingNCT05549102

CBT and the Neural Circuits of Anxiety

This study is recruiting. It focuses on anxiety and currently lists participation information in the United Kingdom.

AnxietyBehavioralFrom 18 Years to 64 Years
Countries
United Kingdom
Sponsor
UCLH/UCL Joint Research Office
Condition
Anxiety
RecruitingNCT06806176

Effectiveness of CAT-GSH for Returning Patients

This study is recruiting. It focuses on depression and currently lists participation information in the United Kingdom.

DepressionBehavioralOver 16 Years
Countries
United Kingdom
Sponsor
University of Sheffield
Condition
Depression
RecruitingNCT07424781

Fluoxetine on Emotional Experience (FLEX) Study

This study is recruiting. It focuses on depression and currently lists participation information in the United Kingdom.

DepressionOtherFrom 18 Years to 24 Years
Countries
United Kingdom
Sponsor
University of Oxford
Condition
Depression
RecruitingNCT05809609

Glutamate Emotion Memory Study

This study is recruiting. It focuses on depression and currently lists participation information in the United Kingdom.

DepressionDrugFrom 20 Years to 60 Years
Countries
United Kingdom
Sponsor
University of Oxford
Condition
Depression
RecruitingNCT06578845

HappyMums Mobile Application Study

This study is recruiting. It focuses on depression and currently lists participation information in Croatia, Finland, Germany, Italy, Poland, and the United Kingdom.

DepressionOtherOver 18 Years
Countries
Croatia, Finland, Germany, Italy, Poland, United Kingdom
Sponsor
King's College London
Condition
Depression
RecruitingNCT06966401

Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)

This study is recruiting. It focuses on depression and currently lists participation information in Belgium, Bulgaria, Croatia, Czech Republic, Estonia, Finland, Hungary, Latvia, Lithuania, the Netherlands, Poland, Romania, Slovakia, Sweden, the United Kingdom, and the United States.

DepressionOtherOver 18 Years
Countries
Belgium, Bulgaria, Croatia, Czech Republic, Estonia, Finland, Hungary, Latvia, Lithuania, Netherlands, Poland, Romania, Slovakia, Sweden, United Kingdom, United States
Sponsor
Neurocrine Biosciences
Condition
Depression